Vol.

40

No.

13

March 28, 2014Mar 28, 2014

Free

DOWNLOAD THE PDF

Cover Story

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test 1

By Matthew Bin Han Ong

The FDA Molecular and Clinical Genetics Panel voted 10-0 to recommend approval of Cologuard—a noninvasive, multitarget stool DNA screening test for colorectal cancer.

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test 2

Ransohoff: Cologuard To Define the Roles of Colorectal Tests

Rising Costs at NCI Threaten to Overtake Slim Increases In Budget Appropriations

By Conor Hale

Recent Issues

Scroll to top

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test 1

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test 2

Ransohoff: Cologuard To Define the Roles of Colorectal Tests

Rising Costs at NCI Threaten to Overtake Slim Increases In Budget Appropriations

In Brief

Caplan Receives NSB Public Service Award

Fazio and Kantarjian Receive Lifetime Achievement Awards

Pienta named director of Johns Hopkins Prostate Cancer Program

American Society of Hematology awards 15 bridge grants

Stewart named incoming president of Patient Advocate Foundation

Ohio State signs agreement with MedVax Technologies Inc.

UC San Francisco signs agreement with Advaxis Inc.

Georgia Regents receives CEO Gold Standard accreditation

The winners of the Research!America Advocacy Awards

European Commission approves MabThera SC

Japan approves LonSurf combination tablet

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login